HR 3520 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
STAND Against Emerging Opioids Act
To amend the Controlled Substances Act to provide for the scheduling of tianeptine as a schedule III substance, and for other purposes.
Summary
The bill amends the Controlled Substances Act to classify tianeptine as a Schedule III controlled substance. The classification includes tianeptine's analogues, salts, isomers, and salts of isomers. The changes take effect 90 days after the bill is enacted.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
2 cosponsors
Money behind the sponsor
Top reported contributors to Jimmy Panetta’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $19,200
- NFP $15,500
- APOLLO GLOBAL MANAGEMENT $13,500
- ROCKET CENTRAL $12,000
- FOLKTALE WINERY $7,760
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Jimmy Panetta → · Outside spending →
Actions (2)
- May 20, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- May 20, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
May 20, 2025
Mr. Panetta (for himself and Mr. Pfluger) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend the Controlled Substances Act to provide for the scheduling of tianeptine as a schedule III substance, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act” or the “STAND Against Emerging Opioids Act”.
SEC. 2. SCHEDULING OF TIANEPTINE.
(a) In General.—Section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end of schedule III the following:
“(f) Tianeptine, including its analogues, salts, isomers, and salts of isomers.”.
(b) Effective Date.—The amendment made by subsection (a) shall become effective on the date that is 90 days after the date of enactment of this Act. <all>
Comments